This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Lead Optimization of receptor antagonist CT0093 for disease-modifying Alzheimers
Investments > €500k
United States of America
Alzheimer’s disease & other dementias
2016